Cytomorphology of a ?Benign Follicular Nodule? of Thyroid
Abdulaziz Radhi S ALjohni, Ahad Amer Alsaiari, Omar Abdulrhman Alfaroq, Amar Hassan Hussain Bashir and Azeza Abdulrhman Alfaroqie
Published: February 05, 2022
DOI: 10.55162/MCMS.02.018
Abstract
There is 4 to 7 percent of the population who have palpable thyroid nodules; nevertheless, there is 19 to 67 percent of the population who have nodules identified accidentally on ultrasonography. The great majority of thyroid nodules do not manifest themselves with symptoms. As malignant nodules account for around 5% of all palpable nodules, the major purpose of investigating thyroid nodules is to rule out the presence of cancer. One of the tests that may be used to differentiate between a thyrotoxic nodule and a euthyroid nodule is the thyroid-stimulating hormone test. Thyroid nodules should be fine-needled aspirated in individuals who are otherwise healthy but have a thyroid nodule, and radionuclide scanning should be reserved for patients with equivocal thyroid cytology or thyrotoxic endocrine disease (thyrotoxicosis). Using ultrasonic guidance during fine-needle aspiration, the frequency of inadequate specimens from fine-needle extraction is reduced. Operation is the most common treatment for malignant lesions, and the amount of the surgery is decided by the severity and kind of the sickness. Postoperative radioactive iodine ablation is done on high-risk patients who have cancer that has spread or that has returned after treatment. However, thyroxine suppression therapy is often employed surgically to treat malignant lesions.
Keywords: Thyroid thyroid nodules; Epidemiologic presentation; Lymphocytic thyroiditis; Diagnosis; Treatment